Citation Impact
Citing Papers
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
2017 Standout
Trends in the prevalence and mortality of cognitive impairment in the United States: Is there evidence of a compression of cognitive morbidity?
2008
Ageing populations: the challenges ahead
2009 Standout
Roles of tau protein in health and disease
2017
Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease
2008
Drug treatments in Alzheimer’s disease
2016
Aminothienopyridazines and Methylene Blue Affect Tau Fibrillization via Cysteine Oxidation
2013
Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis
2010 Standout
Astrocytes: Implications for Neuroinflammatory Pathogenesis of Alzheimers Disease
2011
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
2020 Standout
Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
2013
In search of an anti-inflammatory drug for Alzheimer disease
2020
Big-Loop Recurrence within the Hippocampal System Supports Integration of Information across Episodes
2018 StandoutNobel
Why Olanzapine Beats Risperidone, Risperidone Beats Quetiapine, and Quetiapine Beats Olanzapine: An Exploratory Analysis of Head-to-Head Comparison Studies of Second-Generation Antipsychotics
2006
Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management
2007 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo
2012
Epidemiological Pathology of Dementia: Attributable-Risks at Death in the Medical Research Council Cognitive Function and Ageing Study
2009
Alzheimer's disease
2011 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
A novel small-molecule PROTAC selectively promotes tau clearance to improve cognitive functions in Alzheimer-like models
2021
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
The Genetics of Alzheimer Disease: Back to the Future
2010
Risk Factors for Nursing Home Placement in Alzheimer's Disease: A Longitudinal Study of Cognition, ADL, Service Utilization, and Cholinesterase Inhibitor Treatment
2010
An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex
2014 Standout
Nonmedical Influences on the Use of Cholinesterase Inhibitors in Dementia Care
2007
EFNS guidelines for the diagnosis and management of Alzheimer’s disease
2010
Physicians' Efficacy Requirements for Prescribing Medications to Persons with Alzheimer's Disease
2007
Mixed Dementia
2004
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
Parkinson's disease
2009 Standout
Signs of Preclinical Wernicke's Encephalopathy and Thiamine Levels as Predictors of Neuropsychological Deficits in Alcoholism without Korsakoff's Syndrome
2010
Tau in physiology and pathology
2015 Standout
Olfactory function distinguishes vascular parkinsonism from Parkinson's disease
2004
Super-Enhancers in the Control of Cell Identity and Disease
2013 Standout
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
2017 StandoutNobel
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial
2009
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Prescribing trends in cognition enhancing drugs in Australia
2010
Parkinson's disease
2015 Standout
Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
2008
Behavioral and Psychological Symptoms of Dementia
2012
Tau-aggregation inhibitor therapy for Alzheimer's disease
2013
Donepezil in Alzheimer’s Disease: What to Expect after 3 Years of Treatment in a Routine Clinical Setting
2006
Donepezil and nursing home placement — benefits and costs
2015
Parsing Schizophrenia with Neurocognitive Tests: Evidence of Stability and Validity
1997
A Meta-Analysis of Cytokines in Alzheimer's Disease
2010
Current and evolving treatment strategies for the Alzheimer disease continuum
2020
Alzheimer's disease
2006 Standout
Alzheimer's disease
2016 Standout
Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease
2009
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Anti-Aβ Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease
2011 StandoutNobel
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Olfaction and Parkinson's syndromes: its role in differential diagnosis
2004
Does Donepezil Treatment Slow the Progression of Hippocampal Atrophy in Patients With Alzheimer’s Disease?
2005
Long-term Course and Effectiveness of Combination Therapy in Alzheimer Disease
2008
Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
2013 Standout
Alzheimer's disease: strategies for disease modification
2010
What Learning Systems do Intelligent Agents Need? Complementary Learning Systems Theory Updated
2016 StandoutNobel
The Pathobiology of Vascular Dementia
2013 Standout
How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials
2008
Update on the Pharmacological Treatment of Alzheimers Disease
2010
Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial
2006
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline
2007
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review
2013 Standout
Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease
2009
Treatment with galantamine and time to nursing home placement in Alzheimer's disease patients with and without cerebrovascular disease
2008
Caregiver‐Specific Outcomes in Antidementia Clinical Drug Trials: A Systematic Review and Meta‐Analysis
2005
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
2020 Standout
Guidelines for conducting and reporting economic evaluation of fall prevention strategies
2010
Assessment and management of behavioral and psychological symptoms of dementia
2015 Standout
Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.
1998 Standout
Development of Beta-Amyloid-induced Neurodegeneration in Alzheimer's Disease and Novel Neuroprotective Strategies
2005
Management of agitation and aggression associated with Alzheimer disease
2009
Predictors of caregiver burden in caregivers of individuals with dementia
2011
Current and Future Treatments in Alzheimer Disease: An Update
2020
Pharmacotherapeutic strategies in the treatment of severe Alzheimer’s disease
2016
Australian population trends and disparities in cholinesterase inhibitor use, 2003 to 2010
2013
Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial
2008
Lecanemab in Early Alzheimer’s Disease
2022 Standout
Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis.
2008
Relatives of the Impaired Elderly: Correlates of Feelings of Burden
1980 Standout
Dementia.
2012
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Caregiver Burden
2014 Standout
Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia
2019
Amyloid-β, Tau, and Dementia
2009
Psychological well-being of informal caregivers of elderly people with dementia: Changes over time
1997
Bright Side of Lignin Depolymerization: Toward New Platform Chemicals
2018 Standout
Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade
2018
MDS clinical diagnostic criteria for Parkinson's disease
2015 Standout
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
About Sleep's Role in Memory
2013 Standout
M1 Muscarinic Acetylcholine Receptor Agonism Alters Sleep without Affecting Memory Consolidation
2006
Emerging Therapeutics for Alzheimer's Disease
2014
Effect of Citalopram on Agitation in Alzheimer Disease
2014
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Family caregivers of people with dementia
2009 Standout
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Donepezil for dementia due to Alzheimer's disease
2006
Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology
2017
Interventions for preventing falls in older people living in the community
2012 Standout
Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology
2010
The Necessity of the Medial Temporal Lobe for Statistical Learning
2014
Cholinesterase inhibitors for Alzheimer's disease
2006 Standout
Works of Peter Bentham being referenced
P4‐347: Tau aggregation inhibitor (TAI) therapy with rember™ arrests the trajectory of rCBF decline in brain regions affected by Tau pathology in mild and moderate Alzheimer's disease (AD)
2008
Association study of the GAB2 gene with the risk of developing Alzheimer's disease
2008
Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial
2016
Semantic memory is impaired in schizophrenia
1996
Learning temporal statistics for sensory predictions in mild cognitive impairment
2015
Thiamine for Wernicke-Korsakoff Syndrome in people at risk from alcohol abuse
2004
Proxy completion of EQ-5D in patients with dementia
2005
The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer's disease
2006
Brief Psychosocial Therapy for the Treatment of Agitation in Alzheimer Disease (The CALM-AD Trial)
2009
Determinants of burden in those who care for someone with dementia
2008
Role of Serotonin Transporter Polymorphisms in the Behavioural and Psychological Symptoms in Probable Alzheimer Disease Patients
2007
Donepezil for the Treatment of Agitation in Alzheimer's Disease
2007
Olfactory identification is impaired in clinic‐based patients with vascular dementia and senile dementia of Alzheimer type
2001
The prevalence of depression in the carers of dementia sufferers
1995
O3‐04–07: Tau aggregation inhibitor (TAI) therapy with rember™ arrests disease progression in mild and moderate Alzheimer's disease over 50 weeks
2008
Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial
2004
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease
2019
Memory, frontal and other cognitive impairments in schizophrenia—A neuropsychological study
1991
Tau Aggregation Inhibitor Therapy: An Exploratory Phase 2 Study in Mild or Moderate Alzheimer's Disease
2015